Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the Regulations), Dr. Lal PathLabs has informed about submission of Corporate Presentation of the Company for Q2 FY20, which the Company proposes to share with analysts/ investors.
The above information is a part of company’s filings submitted to BSE.